Pharmaceutical Investing Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan
Pharmaceutical Investing EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update